跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-04
首页
药物
IN-04
IN-04
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF TREATING RHEUMATOID ARTHRITIS USING RNA-GUIDED GENOME EDITING OF HLA GENE
EP 3615674 A4
申请人: UNIV COLORADO REGENTS
优先权: 2017
EP
US
WO
6 件公开
Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
US 8481511 B2
申请人: REN YONG
优先权: 2006
US
5 件公开
Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including Lactobacillus delbrueckii subsp. bulgaricus and N-acetyl D-glucosamine
US 8007783 B2
申请人: MILLER CARL
优先权: 2006
US
4 件公开
增强安丝菌素体内靶标蛋白基因表达的高产安丝菌素方法
CN 113980982 B
申请人: 上海交通大学
优先权: 2021
CN
3 件公开
STREPTOCOCCUS PNEUMONIAE PILUS ANTIGENS
US 2011097360 A1
申请人: DONATI CLAUDIO
优先权: 2008
CN
US
2 件公开
Norrin induced expression of genes and use thereof to treat disease
US 12485158 B2
申请人: RETINAL SOLUTIONS LLC
优先权: 2017
CN
US
2 件公开
DNA aptamers, method for inhibiting human galectin-1 and method of treating a mammal in need thereof
US 11649460 B2
申请人: PEINADO PEREIRA JOAO FRANCISCO
优先权: 2020
CN
US
2 件公开
BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGING
EP 3915537 A1
申请人: DUPONT NUTRITION BIOSCI APS
优先权: 2020
EP
US
2 件公开
FAP INHIBITOR, FAP-TARGETED NUCLIDE PROBE. AND APPLICATION THEREOF
WO 2024222888 A1
申请人: SHANGHAI INST MATERIA MEDICA CAS
优先权: 2023
CN
WO
2 件公开
COMPOSITE MATERIAL OF BISMUTH OXYCARBONATE AND POLYMERS FOR FILTERING ULTRAVIOLET RADIATION
EP 4731165 A1
申请人: OREAL
优先权: 2023
EP
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈